Spray and pray – the COVID-19 version
Kiran Mazumdar-Shaw is the head of Biocon, a company headquartered in Bengaluru and which has repurposed a drug called itolizumab – already approved to help manage severe chronic psoriasis in differen…
Get to the bottom of it
2 posts
Kiran Mazumdar-Shaw is the head of Biocon, a company headquartered in Bengaluru and which has repurposed a drug called itolizumab – already approved to help manage severe chronic psoriasis in differen…
The Print published an article entitled 'Ramdev’s Patanjali does a ‘first’, its Sanskrit paper makes it to international journal' on February 5, 2020. Excerpt: In a first, international scien…